The HIV-1 matrix (MA) protei n contains two subcellular localization signals with opposing effects. A myristoylated N-terminus governs particle assembly at the plasma membrane, and a nucleophilic motif facilitates import of the viral preintegration complex into the nucleus of nondividing cells. Here, we show that myristoylation acts as the MA dominant targeting signal in HIV-1 producer cells. During virus assembly, a subset of MA is phosphorylated on the C-terminal tyrosine by a virion-associated cellular protein kinase. Tyrosinephosphorylated MA is then preferentially transported to the nucleus of target cells. An MA tyrosine mutant virus grows normally in dividing cells, but is blocked for nuclear import in terminally differentiated macrophages. MA tyrosine phosphorylation thus reveals the karyophilic properties of this protein within the HIV-1 preintegration complex, thereby playing a critical role for infection of nondividing cells.
Introduction
Retroviruses are single-stranded RNAviruses whose replication depends on the integration of a double-stranded DNA intermediate, termed the provirus, into the host cell genome. For oncoretroviruses, this process depends on cell proliferation Temin, 1972, 1974) , because the breakdown of the nuclear envelope at mitosis is necessary for bringing the viral preintegration complex in contact with the cell chromosomes (Roe et al., 1993; Lewis and Emerman, 1994) . In contrast, human immunodeficiency virus type 1 (HIV-1) has the ability to infect nondividing cells (Lewis et al., 1992) . This property is shared with other lentiviruses and reflects the existence of determinants that govern the active transport of the viral preintegration complex through the nucleopore (Bukrinsky et al., 1992) . It likely plays a crucial role in AIDS pathogenesis because it allows the spread of HIV-1 in such critical targets as terminally differentiated macrophages (Weinberg et al., 1991) .
Two viral proteins, matrix (MA) and Vpr, have been shown to participate in this process in a partly redundant manner (Bukrinsky et al., 1993a; Heinzinger et al., 1994; von Schwedler et al., 1994) . MA is the N-term inal cleavage product of the HIV-1 Gag precursor by the viral protease and contains a nuclear localization signal (NLS) (Myers et al., 1992 ) that closely resembles the prototypic SV40 large T antigen NLS (Kalderon et al., 1984) . A peptide based on the MA NLS acts as a nuclear targeting sequence when coupled to a heterologous protein in vitro (Bukrinsky et al., 1993a) . In cells acutely infected with H IV-l, MA was detected in fractions containing partially purified HIV-1 preintegration complexes (Bukrinsky et al., 1993b) , as well as in the nucleus (Sharova and Bukrinskaya, 1991) .
In the absence of a functional vpr gene, the critical role of the MA NLS is further revealed: vpr-MA-NLS double mutant viruses show a defect in nuclear import and, as a result, have an impaired ability to infect nondividing cells such as macrophages (Bukrinsky et al., 1993a; Heinzinger et al., 1994; von Schwedler et al., 1994) .
In addition to fulfilling this critical function at an early step of the infection process, MA also plays an essential role in virus morphogenesis. Indeed, a myristate residue at the N-terminus of MA directs Gag to the plasma membrane. This targeting is essential for the proper assembly of viral particles and for their release into the extracellular space (Varmus and Swanstrom, 1984) . In the process, MA also recruits the envelope glycoprotein at the surface of virions (Yu et al., 1992a (Yu et al., , 1992b Dorfman et al., 1994) . Correspondingly, MA has been localized to the periphery of mature HIV-1 particles, bound to the inner leaflet of the virus lipid bilayer (Gelderblom et al., 1987) .
Since the myristoylation signal and the N LS have opposing influences on the subcellular localization of MA, their respective effects must be tightly regulated. The present work reveals the mechanism of this regulation. We find that myristoylation acts as a dominant targeting signal for MA in HIV-1 producer cells, preventing the NLS-mediated nuclear import of the protein. We further demonstrate that a small subset of MA molecules undergo C-terminal tyrosine phosphorylation at the time of particle assembly. Both membrane association and proteolytic cleavage of Gag are necessary for this modification, which can be observed in the absence of other viral proteins. Accordingly, tyrosine phosphorylation can be observed when recombinant MA is exposed to cellular extracts, as well as viral lysates. Although only 1% of all MA molecules internalized by newly infected cells migrate to the nucleus, the majority of those phosphorylated on tyrosine are rapidly translocated to this compartment. Mutating the C-terminal tyrosine of MA to phenylalanine does not alter Gag processing, nor replication of the resulting virus in dividing cells, such as activated T lymphocytes. However, in the absence of a functional vpr gene, the MA tyrosine mutant is profoundly defective for growth in terminally differentiated macrophages, owing to a block in the nuclear import of the viral preintegration complex. These results thus demonstrate that tyrosine phosphorylation reveals the karyophilic function of MA in the context of the HIV-1 preintegration complex, thereby playing a crucial role for infection of nonproliferating cells such as macrophages. 2) is found exclusively in the cytoplasm, whereas large amounts of the two nonmyristoylated forms of MA (lanes 3 and 5) migrate to the nucleus. Nuclear transport of nonmyristoylated MA is greatly reduced by a mutation in the NLS (lanes 4 and 6). CA and the tubulin control are restricted to the cytoplasm. (D) Wild-type MA is tightly bound to the plasma membrane. 293 ceils expressing wild-type and a nonmyristoylated form of MA were separated into plasma membrane, cytosol, and nucleus fractions, followed by immunoprecipitation with MA-specific antibody and Western blotting. (E) Nuclear import of nonmyristoylated MA is blocked by NLS peptide and wheat germ agglutinin (WGA), 293 cells expressing MAGu, were treated overnight as indicated above each lane (minus: mock). Nuclear fractions were then analyzed by immunoprecipitation with MA-specific antibody, followed by Western blotting. The effect of WGA could be prevented by addition of N-acetylglucosamine, as described (Forbes, 1992) .
Results

Myristoylation Prevents the NLS-Mediated
Transport of MA to the Nucleus of HIV-1 Producer Cells Altered forms of the HIV-1 MA protein were generated in the context of a full-length proviral construct ( Figure 1A) . First, two nonmyristoylated variants were created, one by replacing the MA N-terminal glycine by alanine, the second by introducing six histidines at the proximal end of Gag. Both mutations effectively prevented myristoylation (Figure 1 B) . N LS-defective versions of these proteins were also derived by replacing two lysines in the NLS by threonines, a change previously shown to abrogate the function of this motif (von Schwedler et al., 1994) . Cytoplasmic and nuclear extracts of cells transfected with these constructs were then analyzed by Western blotting ( Figure 1C ). Wildtype MA was found exclusively in the cytoplasm ( Figure  1C , lane 2), as was the viral capsid (CA); tubulin, a protein normally restricted to this compartment, sewed as a control. Further separation of the cytoplasm in membrane and cytosol fractions revealed that myristoylated MA was associated with the plasma membrane, as previously described (Varmus and Swanstrom, 1984; Spearman et al., 1994) ( Figure 1D, lanes 1-3) . In contrast, large amounts of both forms of nonmyristoylated MA were associated with the nucleus ( Figure 1C , lanes 3 and 5; Figure 1D , lanes 4-6). This process was NLS-dependent, since mutations in this motif induced the partial redistribution of nonmyristoylated MA to the cytoplasm ( Figure 1C , lanes 4 and 6). Furthermore, the nuclear import of nonmyristoylated MA was effectively blocked by peptide containing the prototypic SV40 large T antigen NLS (Figure 1 E, lanes  1-4) . This correlates the previous demonstration that such peptide can inhibit the MA-mediated nuclear import of the HIV-1 preintegration complex (Gulizia et al., 1994) , as well as that of other karyophiles harboring a related signal (Michaud and Goldfarb, 1993) . Finally, nuclear import of nonmyristoylated MA could be prevented by wheat germ agglutinin ( Figure 1E , lanes 5-7), a lectin that specifically blocks transport through the nuclear pore (reviewed by Forbes, 1992) .
In these experiments, MA was expressed together with the other products of the gag and pol genes, raising the possibility that these additional polypeptides altered its localization. These studies were thus repeated with HIV-1-derived constructs in which the sequence encoding wildtype or nonmyristoylated MA was immediately followed by a stop codon. The respective distribution of these proteins was similar to that observed in the context of full-length precursors, indicating that MA subcellular targeting is independent from other Gag and Pol proteins (data not shown).
MA Molecules Imported to the Nucleus of Newly Infected Cells Are Myristoylated
The above data indicate that MA has intrinsic nucleophilic properties conferred by the NLS, but in virus producer cells, these are masked by myristoylation. Yet, once HIV-1 enters target cells, a functional MA NLS prevails and plays a major role in facilitating the nuclear import of the viral preintegration complex (Bukrinsky et al., 1993a; von Schwedler et al., 1994 
The C-Terminal Tyrosine of MA Is Phosphorylated
Taken together, these results demonstrate that myristoylation acts as a dominant targeting signal for MA during viral particle formation, yet for 1% of the molecules, it becomes recessive once HIV-1 enters target cells. This suggests a model in which some modification of MA, during or after assembly, is responsible for silencing the influence of myristoylation, thereby revealing the NLS effect. Interestingly, the membrane association of HIV-1 Gag depends not only on myristate, but also on nearby positively charged residues predicted to interact with negatively charged phospholipids in the plasma membrane (Zhou et al., 1994) . Such an electrostatic mechanism implies that reversible membrane binding of MA might be achieved by introduction of appropriately placed negative charges into the protein, for instance through phosphorylation. By analogy, platelet-derived growth factor stimulation of 3T3 cells is accompanied by N-terminal phosphorylation of myristoylated pp60 °src, which is then released from the cell membrane (Walker et al., 1993) . Similarly, phosphorylation of membrane-bound myristoylated alanine-rich C kinase substrate (MARCKS) by protein kinase C releases this protein into the cytosol (Thelen et al., 1991) . Based on these precedents, the phosphorylation status of HIV-1 MAwas examined. It was thus found that, in HIV-1 virions purified from acutely infected T lymphoid cells, MA reacted with an anti-phosphotyrosine antibody in Western blots ( Figure 3A , lane 1). The signal could be abolished by prior treatment of viral extracts with calf intestine phosphatase ( Figure 3A , lane 2), unless the phosphatase inhibitor orthovanadate was added ( Figure 3A , lane 3). MA tyrosine phosphorylation was not restricted to T cell-produced virus, as it was also observed with virions purified from the supernatant of transfected fibroblasts ( Figure 3B ). HIV-1 MA contains three highly conserved tyrosines, at positions 29, 86, and 132, respectively (Myers et al., 1992) . Each of these tyrosines was changed individually to phenylalanine, in the context of a full-length proviral construct. Virions obtained from cells transfected with the resulting plasmids were analyzed by anti-phosphotyrosine Western blotting ( Figure 3B ). This identified the C-terminal tyrosine of MA, at position 132, as the target of phosphorylation. Phosphoamino acid analysis of virions produced from 32p. labeled cells confirmed that MA is phosphorylated on Tyr- 
Requirements for MA Tyrosine Phosphorylation
The requirements for MA tyrosine phosphorylation were then determined. It revealed that this modification was dependent on the plasma membrane association of Gag, as nonmyristoylated forms of MA were not tyrosine phosphorylated ( Figure 4A , lanes 1 and 2). If MA was produced in the absence of other Gag and Psi proteins, its exposed C-terminus underwent tyrosine phosphorylation ( Figure  4A , lane 4). However, no phosphotyrosine was detected in the p55 Gag precursor, whether it was produced in normal amounts by wild-type virus or accumulated by a proteasedefective mutant ( Figure 4A , lane 5). The need for Gag proteolytic cleavage implies that MA tyrosi ne phosphorylation is coupled with virus maturation, as might be expected for a regulatory event controlling, in a timely manner, the karyophilic properties of this protein.
To explore further the factors important for MA tyrosine phosphorylation, a chimeric integral membrane protein was constructed, with an extracellular and transmembrane region derived from CD4 and a cytoplasmic domain made by MA. A variant of this chimera, in which the C-terminal tyrosine of MA was changed to phenylalanine, served as control. These proteins, called 44MA and 44MAyt32F, respectively, were then analyzed by Western blotting with MA-and phosphotyrosine-specific antibodies ( Figure 4B ). The result showed that the tyrosine phosphorylation of the MA C-terminus occurred efficiently in the 44MA protein.
It confirmed that this process is independent of the recognition of a specific receptor by the myristoylated end of MA. Furthermore, it demonstrated that MA tyrosine phosphorylation does not require particle formation per se, nor the presence of any other viral protein. . Nuclear import of MA is blocked, but tyroeine-phosphorylated species are still detected, demonstrating that they are not generated in the nucleus.
The pattern of tryptic phosphopeptides of phosphorylated MA molecules obtained in these experiments was examined and found to be comparable to that observed with virus-associated MA labeled in vivo (data not shown). Significant levels of MA serine, threonine, and tyrosine kinase activities were also found in HIV-1 virions, purified from a chronically infected human T lymphoid cell line by size fractionation ( Figure 5C, left) . Moreover, the MA protein kinase activity remained associated with the viral particles when these were purified further by immunoprecipitation with antibodies against the viral envelope ( Figure 5C , right).
Tyrosine-Phosphorylated MA Is Rapidly Imported to the Nucleus of Newly Infected Cells
To ask whether tyrosine phosphorylation influences the karyophilic properties of MA, growth-arrested cells were exposed to HIV-1 and fractionated in cytoplasmic and nuclear fractions, at various times postinfection. These fractions were then analyzed by Western blotting, with MAand phosphotyrosine-specific antibodies (Figures 6A and 6B). As seen previously (Figure 3 ), the vast majority of MA molecules remained associated with the cytoplasm. In contrast, most of those phosphorylated on tyrosine were rapidly transported to the nucleus. If cells were treated with NLS peptide, total levels of phosphotyrosine-containing MA were not significantly changed, but this protein was retained in the cytoplasm ( Figure 6C ). This indicates that the nuclear accumulation of tyrosine-phosphorylated MA does not reflect de novo phosphorylation in this compartment, but instead the rapid and preferential translocation of this protein from the cytoplasm to the nucleus of acutely infected cells.
MA Tyrosine Phosphorylation Is Accomplished by a Cellular Protein Kinase Present in Virions
The last point implied that a cellular kinase is responsible for MA tyrosine phosphorylation. This was tested by in vitro kinase assays employing recombinant MA protein as substrate ( Figure 5 ). When incubated in the presence of reaction buffer and ATP, MA did not autophosphorylate. In contrast, phosphate moieties were transferred from [y-32P]ATP to MA, when either crude extracts of CEM or 293 cells or pelleted CEM supernatant were added ( Figure  5A ). Greater levels of 3~p incorporation were seen when pelleted cell supernatant, as opposed to cellular extract, was used as the source of protein kinase activity. However, this was due to higher levels of endogenous ATP in the cells, which interfered with the incorporation of 32p into the MA substrate: when reactions were normalized by adding nonradioactive ATP to 20 raM, cell extracts were found to be more effective at phosphorylating MA (data not shown). In these in vitro assays, incorporation of phosphate was less efficient on tyrosine than on serine, and some phosphothreonine was also observed, whereas none was found with in vivo labeled MA. However, the C-terminal tyrosine of MA was specifically modified, as no phosphotyrosine was recovered when reactions were performed on a recombinant MAy~32F variant ( Figure 5B ).
An HIV-1 Strain Defective for MA Tyrosine Phosphorylation Is Blocked for Growth in Terminally Differentiated Macrophages Owing to a Defect in Nuclear Import
Our findings were compatible with a role for MA tyrosine phosphorylation in HIV-1 nuclear import and, hence, for infection of nondividing cells. To probe this issue, the replication of viruses containing wild-type and phosphotyrosine-defective versions of MA were compared under conditions of cell proliferation and growth arrest. A virus with a mutation in the MA NLS served as additional control, as it was previously shown to be defective specifically in nondividing cells (von Schwedler et al., 1994) . Since Vpr can partly substitute for MA in facilitating the nuclear migration of HIV-1 in nonmitotic targets (Heinzinger et al., 1994) , these experiments were done with viral strains carrying a defective vprgene. Substituting a phenylalanine for the C-terminal tyrosine of MA did not alter Gag processing (Figure 3 ) nor replication of the resulting HIV-1 mutant in activated peripheral blood lymphocytes (Figure 7, top) . However, like the MA NLS mutant, this variant was unable to grow in terminally differentiated macrophages ( Figure  7 , bottom). To examine further this parallel and to determine the level at which the replication of the tyrosine mutant was 3o I blocked, viral DNA synthesis in freshly infected macrophages was studied. The accepted model for reverse transcription includes a series of steps, beginning with the synthesis of DNA complementary to the U5 and R regions of the viral long terminal repeat (minus-strand strong-stop DNA), continuing with the elongation of this minus-strand after a first template switch, and culminating in the generation of a full-length double-stranded DNA molecule following a second template switch. Once the viral DNA is transported to the nucleus, full-length linear molecules can circularize either by ligation of their two ends or through recombinatorial events (Varmus and Swanstrom, 1984) . The appearance of these various intermediates and products of reverse transcription was thus monitored by polymerase chain reaction (PCR), in terminally differentiated macrophages acutely infected with the HIV-l-derived viruses (Figure 8 ). This revealed that the phosphotyrosinedefective virus directed the synthesis of wild-type amounts of viral linear DNA, indicating that its entry and reverse transcription proceeded normally. In contrast, and like the NLS mutant, this variant produced much lower levels of viral DNA circles compared with wild type. These results indicated that the absence of tyrosine at the C-terminal end of MA specifically impairs the nuclear import of HIV-1 DNA. These data thus allow us to conclude that tyrosine phosphorylation reveals the karyophilic properties of MA in the context of the HIV-1 preintegration complex, thereby playing an esential role for infection of terminally differentiated macrophages. were analyzed by PCR at the indicated timepoints, with primers specific for various products of reverse transcription. EL, early linear products (elongated minus-stand DNA); LL, late linear products (generated after the second template switch); Ci, two-LTR circles (formed in the nucleus). Both MA mutants induce wildtype levels of linear DNA but dramatically reduced amounts of circles.
Discussion
The HIV-1 MA protein fulfills two crucial functions at different stages of the virus life cycle, as it is required for both particle assembly and nuclear import of the viral preintegration complex. The myristoylation signal and the NLS, which exert contradictory influences on the subcellular localization of MA, are each essential for one of these two functions. Here, we present a model for the regulatory mechanism that allows MA to play its dual role. We first show that myristoylation acts as a dominant targeting signal for MA in virus producer cells, leading to particle formation at the plasma membrane and release of new virions into the extracellular space. We then demonstrate that a small subset of MA molecules undergo tyrosine phosphorylation. The dependence of this process on both membrane association and proteolytic cleavage of Gag suggests that it occurs concomitantly with virus maturation. A protein kinase activity that transfers phosphate to the C-terminal tyrosine of recombinant MA can be detected in cells as well as in purified virions. A crucial link between MA tyrosine phosphorylation and the subsequent import of the HIV-1 preintegration complex is revealed by two lines of evidence. First, there is rapid translocation of tyrosine-phosphorylated MA to the nucleus of newly infected cells, whereas the bulk of MA, not phosphorylated on tyrosine, remains at the plasma membrane. Second, a mutant virus in which the critical MA tyrosine is changed to phenylalanine is selectively impaired for growth in terminally differentiated macrophages, owing to a block in nuclear import.
MA Tyrosine Phosphorylation and HIV-1 Nuclear Import: Potential Mechanisms
The nucleophilic properties of several other proteins are derepressed following phosphorylation, For instance, treat-ment of cells with interferon-a (IFN-~) induces tyrosine phosphorylation and nuclear translocation of the IFN-ccstimulated gene factor 3 (ISGF3), a transcriptional regulator involved in mediating cellular responses to the cytokine (Schindler et al., 1992) . In that case, an interaction between the phosphotyrosine and an SH2 domain mediates the dimerization of the protein, perhaps exposing a yet unidentified nucleophilic motif (Shuai et al., 1994) . Also, the nuclear import of SV40 large T antigen is significantly reduced when sequences flanking the NLS and containing casein kinase II (CKII) phosphorylation sites are removed (Rihs and Peters, 1989) . This might reflect an increased affinity of phosphorylated T antigen for a cytoplasmic receptor responsible for its routing to the nuclear envelope. It is likely that tyrosine phosphorylation enhances the nuclear transport of HIV-1 MA through a different mechanism. Indeed, nonmyristoylated MA is effectively imported to the nucleus even though it is not tyrosine phosphorylated (Figures 1 and 4) . Based on this, it is probable that phosphorylation triggers the redistribution of MA from the membrane to the inner region of the virus, thereby allowing the NLS to play its role in the context of the viral preintegration complex. This could be accomplished by at least two nonmutually exclusive mechanisms: by simply disrupting interactions between MA and the viral membrane, or by stimulating the binding of MA to another component of the viral core nucleoprotein complex.
Membrane release of MA could result from a major conformational change in the protein following phosphorylation. However, a more subtle mechanism could achieve the same result. Indeed, the proximal region of HIV-1 Gag contains a bipartite membrane targeting signal, comprising the myristoylated N-terminal 14 residues, plus an adjacent sequence of 17 amino acids, a number of which are positively charged (Spearman et al., 1994; Zhou et al., 1994) . This more distal region, which has been shown to bind to acidic phospholipids in vitro (Zhou et al., 1994) , is predicted to establish electrostatic interactions with negatively charged phospholipids located on the inner leaflet of the membrane bilayer. Thus, by introducing negative charges in MA, phosphorylation could disrupt these interactions, thereby releasing the protein from the plasma membrane. A similar mechanism has been shown to account for the release of myristoylated pp60 ~~'° and MARCKS from the plasma membrane into the cytosol following phosphorylation by protein kinases A and C, respectively (Walker et al., 1993; Thelen et al., 1991) . With MA, detachment from the membrane would unleash the karyophilic potential conferred by the NLS.
However, two arguments can be advanced against this simple model. First, the tyrosine that becomes phosphorylated is at a significant distance from the region of MA involved in membrane binding, not only considering a linear map of the protein but also its recently proposed structure (Matthews et al., 1994) . Second, tyrosine-phosphorylated MA is detected in virus producer or MA-expressing cells (Figure 1 ; data not shown), yet in these cells it resides in the cytoplasm but not the nucleus. This suggests that an additional factor potentiates the effect of MA tyrosine phosphorylation once HIV-1 leaves producer cells.
On the one hand, there could be an additive effect of MA serine phosphorylation, and in agreement with such a model, our preliminary studies indicate that this modification too is coupled to virus maturation (S. S. and D. T., unpublished data). Alternatively, it could be that MA is preferentially released from the membrane of virions rather than from the membrane of virus producer cells. In that respect, the fluidity and lipidic composition of the HIV-1 membrane have been shown to significantly differ from those of the host cell plasma membrane (Aloia et al., 1993) . Finally, tyrosine phosphorylation could trigger an association between MA and one of the proteins that are directed to the central region of the core during virus maturation and are ultimately involved in forming the virus preintegration complex, such as the integrase and the reverse transcriptase. The nuclear magnetic resonance analysis of MA predicts that the C-terminal 20 amino acids of the protein do not adopt a rigid conformation and, therefore, might be available for such an interaction (Matthews et al., 1994) .
An implication of all the above models is that tyrosinephosphorylated MA molecules might be found inside the viral core. Previous immunoelectron microscopic studies have instead localized MA at the periphery of virions, tightly bound to the inner leaflet of the virus membrane (Gelderblom et al., 1987) . However, of the 1500 MA molecules estimated to be present in each virion (Gelderblom, 1991) , on the basis of our data, we would not expect more than 1°, or approximately 15, to be associated with the core. Indeed, this represents the fraction subsequently imported to the nucleus of newly infected cells (Figure 3) . It is reasonable to assume that such a small number of MA molecules would have escaped detection by electron microscopy. Another prediction derived from our experiments is that, following fusion of the virus and target cell membranes, tyrosine-phosphorylated MA molecules are the ones whose NLS is recognized by a cytoplasmic chaperone responsible for leading the preintegration complex to the nucleopore (Adam and Gerace, 1991; Forbes, 1992) . Our preliminary analyses show that MA molecules contained in the preintegration complex are indeed phosphorylated on tyrosine, supporting this hypothesis (P. G. and D. T., unpublished data).
A Virus-Associated Cellular Protein Kinase Responsible for MA Tyrosine Phosphorylation
The data presented here provide strong evidence indicating that MA tyrosine phosphorylation is accomplished by a cellular protein kinase. The MA tyrosine kinase activity is not restricted to T lymphocytes but is also found in fibreblasts. It fails to phosphorylate nonmyristoylated MA, and so it is likely associated with the cell membrane. This activity can also be detected in the cell supernatant, most probably due to cellular breakdown, rather than to secretion. Remarkably, the MA tyrosine kinase is present in HIV-1 virions purified by size fractionation followed by immuneprecipitation with anti-envelope antibodies. Whether this reflects the stable binding of the enzyme to its MA substrate or the passive incorporation of a membrane-bound enzyme in budding virions is still to be defined. The target of the tyrosine kinase is the last amino acid of MA, a previously unseen placement for a phosphotyrosine. Only the free end of MA is recognized, either after it is liberated by proteolytic cleavage of the Gag precursor or when it is naturally exposed, for instance in the MAsToP and 44MA molecules (Figure 4 ). This appears to permit a coupling between virus maturation and MA tyrosine phosphorylation.
The MA tyrosine kinase remains to be formally identified. However, the present work establishes that it plays a crucial role in facilitating HIV-1 replication in terminally differentiated macrophages, cells thought to be critical for both the persistence and the dissemination of the infection (Gartner and Popovic, 1990) . Efforts aimed at identifying compounds that block MA tyrosine phosphorylation are thus warranted, as they may lead to novel therapies for slowing the spread of the virus in HIV-infected individuals.
Experimental Procedures
DNA Constructions
PCR-mediated mutagenesis was used to introduce site-specific mutations in the MA-or protease-encoding regions of plasmid R7 (Kim et al., 1989; yon Schwedler et al., 1993) , which contains the HIV-1HXB2D provirat DNA (Shaw et al., 1984) with a full-length nef reading frame, as well as in R7BaL, which encodes a macrophage-tropic virus (von Schwedler et al., 1994) . Both R7 and R7BaL produce a truncated Vpr protein, 78 amino acids in length, previously shown to be unable to substitute for the NLS function of MA in macrophages (von Schwedler et al., 1994) . The MAG~ variant has the N-terminal glycine of Gag changed to alanine. The proximal sequence of the MA,H,, protein is Met/Gly/(His)JSer, in which Ser is normally the sixth residue of Gag. APro has a 45 nt deletion in the pol gene (bases 2384-2428, as numbered by Ratner et al., 1985) . The various mutations were also introduced in a modified proviral DNA construct, 3E-neo, which expresses an env-defective version of R7 and contains the sequence encoding for neomycin phosph0transferase instead of nef (Trono, 1992) . The 44MA and 44MA~132F chimeras were constructed by PCR, introducing a unique cloning site at the junction between the transmembrane region of CD4 and the N-terminal end of MA, in the context of a CMVbased expression vector (Aiken et al., 1994) . Recombinant MA carrying an N-terminal histidine tag was produced in Escherichia coil using the bacterial expression vector pET-15b (Novagen) and purified by affinity chromatography on a nickel-Sepharose column according to the instructions of the manufacturer. Cells All cells were maintained as previously described (Aiken et al., 1994; von Schwedler et al., 1994) . HIV-t-infected Molt IIIB human T lymphoid cell lines were obtained from C. Farnet through the NIH AIDS Research and Reference Program. HeLa-derived P4-2 cells (Charneau et al., 1990) were a gift from F. Clavel. Peripheral blood lymphocytes (PBLs) and monocyte-derived macrophages were purified as previously described (von Schwedler et al., 1994) . Macrophages were kept in culture for 2 weeks before infection. For stimulation, PBLs were incubated with phytohemagglutinin (Bethesda Research Laboratories) at 3 ~g/ ml for 48 hr and then maintained in RPMI 1640 containing 10% fetal calf serum and recombinant interleukin-2 (Sigma) at 10 U/ml. To induce growth arrest, P4-2 cells were exposed for 20 min to a 61Co source calibrated at 200 rad/min. After irradiation, cells were diluted for infection to 1 x 106/ml and plated. The arrested state of the cells at the time of infection was verified by propidium iodide staining of their DNA and flow cytometry to ascertain that all cells were in the G2 phase of the cycle. Stable 293 cell lines expressing various MA variants, as well as APro, were created by transfection with LIE-neo-derived plasraids and selection in 0.5 mg/ml G418.
TransfecUons and Infections
Tranfections and preparations of viral stocks were as previously described (von Schwedler et al., 1993; Aiken et al., 1994) . Infections of PBLs (2 x 106 cells) and macropbages (0.5 x 10 e cells) were performed with 20 ng of p24 of 293 cell-produced viruses as previously described (von Schwedler et al., 1994) . For virus growth curves, cells were washed extensively after virus adsorption and p24 antigen production was monitored by ELISA (DuPont). Experiments were repeated many times with cells from different donors, with similar resu Its. In rare instances, however, both NLS and tyrosine mutants showed a less pronounced phenotype, perhaps linked to the state of arrest or differentiation of the macrophages. To follow MA nuclear import, infections of P4-2 irradiated cells were performed either by coculture with Molt IIIB cells at a ratio of 50 to 1, or by the addition of cell-free virus purified from the same cells (5 p.g of p24 antigen per 3 x 107 P4-2 cells). In the experiments of Figure 2 , infections were performed using cell-free virus produced by Molt IIIB cells radiolabeled for 20 hr, either with 200 p.Ci/ml of Tran~S-label (ICN) or with 500 i~Ci/ml of [3H]myristic acid (Amersham). Virions used for in vitro kinase assays were prepared by gel fractionation on a Sephacryl S-100O column as previously described (Trono, 1992) .
Western Blots and Immunoprecipitstions
Rabbit anti-HIV-1 MA serum was obtained by immunization with the above described recombinant histidine-tagged HIV-1 MA protein.
Monoclonal antibodies against p24/p55 (ST-3) and tubulin were purchased from Bethesda Research Laboratories and Boehringer Mannhelm, respectively. Rabbit anti-phosphotyrosine serum was a gift from B. Seffon, Salk institute. Of note, several commercially available antiphosphotyrosine monoclonal antibodies failed to recognize the tyrosine-phosphorylated form of MA. Western blot and immunoprecipitation studies were as previously described (Aiken et al., 1994) .
Subcellular FracUonation
Cells were lysed in cold hypotonic buffer (20 mM potassium HEPES [pH 7.8], 5 mM potassium acetate, 0.5 mM MgCI2, 0.5 mM dithiothreitol, 1 mM sodium orthovanadate, 1 p.g/ml leupeptin, 1 p~g/ml aprotinin, 1 ~g/ml pepstatin A, 1 mM phenylmethylsulfonyl fluoride [PMSF]) using several strokes of a Dounce homogenizer as described by Sugasawa et al. (1990) . Nuclear preservation during cell lysis was followed by phase-contrast microscopy. Cytoplasmic and nuclear extracts were separated by centrifugation at 750 x g for 5 rain, and nuclei were extracted with a hypertonic buffer (20 mM potassium HEPES [pH 7.8], 0.5 mM MgCI2, 500 mM potassium acetate, 0.5 mM dithiothreitol, 1 mM sodium orthovanadate, 1 p.g/ml leupeptin, 1 ~g/ml aprotinin, 1 p.g/ml pepstatin A, 1 mM PMSF). Membrane and cytosol fractions were isolated from cytoplasmic extracts as described (Lin et al., 1991) . High pressure liquid chromatography (H PLC)-purified peptides corresponding to the prototypic SV40 T antigen NLS in the sense (PKKKR-KVEDPYC) and reverse (PDEVKRKKKPYC) orientations were used as described (Gulizia et al., 1994) . Wheat germ agglutinin (WGA) was used at 10 I~M, with or without addition of N-acetylglucosamine (450 I~M), as described in Finlay et al. (1987) .
Phosphorylation Studies
HIV-1 DNA (40 I~g) was transfected into 5 × 106 CEM ceils by electroporation. At the peak of p24 viral antigen production, ceils were radiolabeled with 35 mCi of ~P H3PO4 (DuPont) for 48 hr at 37°C. Labeled virions were first filtered and pelleted, and then incubated for 10 rain in viral lysis buffer (12 mM Tris-HCI [pH 8.0], 0.5% Triton X-100, 300 mM NaCI, 1 mM MgCI2, 0.5 mM dithiothreitol, and 100 rim sodium orthovanadate). M A protein was the n immunoprecipitated with a monoclonal anti-HIV-1 IIIB MA antibody (Advanced Biotechnologies Inc.)on protein A-Sepharose beads. After SDS-PAGE and electrobiotting to polyvinylidene difluoride (PVDF) membrane, phosphorylated MA was visualized by autoradicgraphy and analyzed further for phosphoamino acid content, essentially as described by Boyle et al. (1991) .
PCR Analysis of Acutely Infected
Cells PCR analysis was performed as previously described (yon $chwedler et al., 1993) . The sequences of HIV-specific primers are as follows (positions of nucleotides in the HIV-1H×B~D sequence, according to Ratner etal. [1985] , are indicated in parentheses . Vif6 plus Vif7 amplify elongated minus-strand DNA, LTR5 plus 5NC2 amplify double-stranded molecules generated after the second template switch, and LTR8 plus LTR9 amplify two-LTR circles.
